https://www.wsj.com/health/pharma/bristol-myers-to-buy-karuna-therapeutics-for-14-billion-6a6c1bce
Cash deal would help Bristol establish a beachhead in neuroscience drugs, including a schizophrenia treatment up for approval
Create an account or login to join the discussion